Shanghai INT Medical Instruments Co., Ltd. (INT MEDICAL, 01501) will convene a board meeting on 27 March 2026 in Shanghai. According to the company’s announcement, directors will review and approve the audited annual results of INT MEDICAL and its subsidiaries for the financial year ended 31 December 2025. The agenda also includes the potential declaration of a final dividend.
The notice was signed by Chairman Dr. Liang Dongke and dated 17 March 2026. The board currently consists of two executive directors, four non-executive directors and three independent non-executive directors.